NCT03478943Unknown不适用
The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Disease-free surviva
研究概览
简要总结
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients .
- •Confirmed by Pathology or histology of Gastric cancer.
- •Patients should be voluntary to the trial and provide with signed informed consent.
- •The researchers believe patients can benefit from the study.
排除标准
- •Patients with a known history of allergic reactions and/or hypersensitivity attributed to apatinib or its accessories.
- •Pregnant or lactating women.
- •Patients with Apatinib contraindications.
- •Patients of doctors considered unsuitable for the trial.
结局指标
主要结局
Disease-free surviva
时间窗: 1 year
Progress free survival
时间窗: 1 year
次要结局
- overall survival(3 year)
- Objective Response Rate(1 year)
- Disease Control Rate(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui ProvinceGastric CancerNCT03333967The First Affiliated Hospital of Anhui Medical University1,000
Unknown
不适用
A Real World Study of Apatinib in Treatment of Patients With Gastric CarcinomaGastric CarcinomaNCT03735511Henan Cancer Hospital270
Unknown
2 期
Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal CancerNeoadjuvant TherapyColorectal CancerNCT03377842Sichuan Provincial People's Hospital100
Unknown
2 期
Apatinib as First -Line Treatment for Advanced Esophagus CancerAdvanced Esophagus CancerNCT03542422Affiliated Hospital of North Sichuan Medical College50
Unknown
2 期
XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric CancerGastric CancerNCT01412294Epidemiological and Clinical Research Information Network40